Clinical Trial Update: PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating quantitative PET/CT assessment of myocardial blood flow changes in cancer patients treated with checkpoint inhibitor thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-08-08